{"product_id":"global-g-protein-coupled-receptor-gpcr-targeting-market-growth-2023-2029","title":"Global G-Protein Coupled Receptor (GPCR) Targeting Market Growth 2023-2029","description":"\u003cp\u003eGlobal G-Protein Coupled Receptor (GPCR) Targeting Market Growth 2023-2029\u003c\/p\u003e\n\n\u003cp\u003eG protein–coupled receptors (GPCRs) which are also known as seven-transmembrane domain receptors, 7TM receptors, heptahelical receptors, serpentine receptor, and G protein–linked receptors (GPLR), constitute a large protein family of receptors that detect molecules outside the cell and activate internal signal transduction pathways and, ultimately, cellular responses. Coupling with G proteins, they are called seven-transmembrane receptors because they pass through the cell membrane seven times.\u003cbr\u003e\nLPI (LP Information)' newest research report, the “G-Protein Coupled Receptor (GPCR) Targeting Industry Forecast” looks at past sales and reviews total world G-Protein Coupled Receptor (GPCR) Targeting sales in 2022, providing a comprehensive analysis by region and market sector of projected G-Protein Coupled Receptor (GPCR) Targeting sales for 2023 through 2029. With G-Protein Coupled Receptor (GPCR) Targeting sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world G-Protein Coupled Receptor (GPCR) Targeting industry.\u003cbr\u003e\nThis Insight Report provides a comprehensive analysis of the global G-Protein Coupled Receptor (GPCR) Targeting landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M\u0026amp;A activity. This report also analyzes the strategies of leading global companies with a focus on G-Protein Coupled Receptor (GPCR) Targeting portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global G-Protein Coupled Receptor (GPCR) Targeting market.\u003cbr\u003e\nThis Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for G-Protein Coupled Receptor (GPCR) Targeting and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global G-Protein Coupled Receptor (GPCR) Targeting.\u003cbr\u003e\nThe global G-Protein Coupled Receptor (GPCR) Targeting market size is projected to grow from US$ 86 million in 2022 to US$ 103.7 million in 2029; it is expected to grow at a CAGR of 103.7 from 2023 to 2029.\u003cbr\u003e\nGlobal G-Protein Coupled Receptor (GPCR) Targeting key players include Thermo Fisher Scientific, PerkinElmer, Merck, BD Biosciences, Molecular Devices etc. Global top five manufacturers hold a share over 40%. \u003cbr\u003e\nNorth America is the largest market, with a share over 40%, followed by Japan and Europe, both have a share over 35% percent. \u003cbr\u003e\nIn terms of product, GPCR Consumables is the largest segment, with a share over 60%. And in terms of application, the largest application is Oncology followed by Cardiovascular System.\u003cbr\u003e\nThis report presents a comprehensive overview, market shares, and growth opportunities of G-Protein Coupled Receptor (GPCR) Targeting market by product type, application, key manufacturers and key regions and countries.\u003cbr\u003e\nMarket Segmentation:\u003cbr\u003e\nSegmentation by type\u003cbr\u003e\n GPCR Consumables\u003cbr\u003e\n GPCR Equipment\u003cbr\u003e\nSegmentation by application\u003cbr\u003e\n Oncology\u003cbr\u003e\n Cardiovascular System\u003cbr\u003e\n Central Nervous System\u003cbr\u003e\n Other\u003cbr\u003e\nThis report also splits the market by region:\u003cbr\u003e\n Americas\u003cbr\u003e\n United States\u003cbr\u003e\n Canada\u003cbr\u003e\n Mexico\u003cbr\u003e\n Brazil\u003cbr\u003e\n APAC\u003cbr\u003e\n China\u003cbr\u003e\n Japan\u003cbr\u003e\n Korea\u003cbr\u003e\n Southeast Asia\u003cbr\u003e\n India\u003cbr\u003e\n Australia\u003cbr\u003e\n Europe\u003cbr\u003e\n Germany\u003cbr\u003e\n France\u003cbr\u003e\n UK\u003cbr\u003e\n Italy\u003cbr\u003e\n Russia\u003cbr\u003e\n Middle East \u0026amp; Africa\u003cbr\u003e\n Egypt\u003cbr\u003e\n South Africa\u003cbr\u003e\n Israel\u003cbr\u003e\n Turkey\u003cbr\u003e\n GCC Countries\u003cbr\u003e\nThe below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.\u003cbr\u003e\n Thermo Fisher Scientific\u003cbr\u003e\n PerkinElmer\u003cbr\u003e\n Merck\u003cbr\u003e\n BD Biosciences\u003cbr\u003e\n Molecular Devices\u003cbr\u003e\n Promega\u003cbr\u003e\n Qiagen\u003cbr\u003e\n Abcam\u003cbr\u003e\n Corning\u003cbr\u003e\n Cisbio\u003cbr\u003e\n Discoverx\u003cbr\u003e\n Enzo Life Sciences\u003cbr\u003e\nKey Questions Addressed in this Report\u003cbr\u003e\nWhat is the 10-year outlook for the global G-Protein Coupled Receptor (GPCR) Targeting market?\u003cbr\u003e\nWhat factors are driving G-Protein Coupled Receptor (GPCR) Targeting market growth, globally and by region?\u003cbr\u003e\nWhich technologies are poised for the fastest growth by market and region?\u003cbr\u003e\nHow do G-Protein Coupled Receptor (GPCR) Targeting market opportunities vary by end market size?\u003cbr\u003e\nHow does G-Protein Coupled Receptor (GPCR) Targeting break out type, application?\u003cbr\u003e\nWhat are the influences of COVID-19 and Russia-Ukraine war?\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The report will take approximately 2 business days to prepare and deliver.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"January, 2023 \/ 109 Pages \/ MCW16226147","offer_id":47640119673138,"sku":null,"price":4392.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/global-g-protein-coupled-receptor-gpcr-targeting-market-growth-2023-2029","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}